AOD-9604 is a synthetic peptide fragment derived from
the C-terminal end (amino acids 176�191) of human
growth hormone (HGH). It was originally developed to
isolate the fat-burning effects of HGH without the
growth-related or metabolic side effects. AOD stands for
�Anti-Obesity Drug,� and it has become a popular
compound in body recomposition protocols, often
stacked with GLP-1s or other peptides to target
stubborn adipose tissue.
Unlike HGH, AOD-9604 does not affect IGF-1 levels,
insulin sensitivity, or blood sugar, making it safer and
more focused for fat loss applications.

AOD-9604

$280.00

Excluding Sales Tax |

Quantity

AOD-9604 is a synthetic peptide fragment derived from the C-terminal end (amino acids 176�191) of human growth hormone (HGH). It was originally developed to isolate the fat-burning effects of HGH without the growth-related or metabolic side effects. AOD stands for �Anti-Obesity Drug,� and it has become a popular compound in body recomposition protocols, often stacked with GLP-1s or other peptides to target stubborn adipose tissue. Unlike HGH, AOD-9604 does not affect IGF-1 levels, insulin sensitivity, or blood sugar, making it safer and more focused for fat loss applications.
AOD-9604 is typically used for: Accelerated fat burning and body recomposition Targeted reduction of abdominal and visceral fat Inhibition of new fat formation (antilipogenesis) Non-hormonal, non-suppressive fat loss support Safe to combine with GLP-1s or other peptides Joint repair and anti-inflammatory benefits No impact on glucose, IGF-1, or growth hormone axis Effects are typically seen after consistent use for at least 2�3 months, and one-month standalone use is generally insufficient for noticeable fat loss.
AOD-9604 targets lipolysis and lipogenesis� the body�s natural processes of breaking down and storing fat. It stimulates the betaadrenergic receptors on adipocytes (fat cells), enhancing the release of stored triglycerides into the bloodstream to be burned as fuel. At the same time, it inhibits the formation of new fat, particularly in visceral and abdominal regions. Because it acts selectively on adipose tissue receptors and not the full growth hormone receptor pathway, AOD-9604 avoids undesired effects like bone growth, elevated blood sugar, or fluid retention. It also exhibits antiinflammatory and cartilage-regenerating properties, showing promise in joint healing and osteoarthritis. This makes AOD-9604 ideal as a complement to GLP-1 agonists in individuals who need enhanced fat metabolism, particularly those with 30 lbs or more of excess fat, or in patients not responding optimally to GLP-1 therapy alone.
AOD-9604 has demonstrated a high safety profile in clinical trials. It is non-toxic, nonimmunogenic, and non-hormonal. No significant side effects have been reported, and it does not suppress natural GH production or insulin function. It is best used as part of a multi-month fat loss strategy, especially when combined with diet, movement, and other hormone-balancing peptides like Semaglutide or Tirzepatide.

AOD-9604

Clinical Overview

Benefits

Mechanism of Action

Safety Considerations

Dosing

Monarch Aesthetics